Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 11.3B | 12.1B | 10.9B | 10.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.0B | 4.3B | 3.9B | 3.9B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 4.0B | 4.7B | 3.8B | 3.9B |
Tax provision | 816.3M | 942.2M | 718.6M | 641.9M |
Net income | 3.2B | 3.7B | 3.1B | 3.2B |
Basic EPS | 3.0 | 3.5 | — | 3.1 |
Diluted EPS | 3.0 | 3.5 | — | 3.1 |
Basic average shares | 1.0B | 1.0B | — | 1.0B |
Diluted average shares | 1.0B | 1.0B | — | 1.0B |
EBITDA | — | — | — | — |
Net income from continuing op. | 3.2B | 3.7B | 3.1B | 3.2B |
Minority interests | -2.9M | -1.4M | -2.2M | -2.2M |
Preferred stock dividends | — | — | — | — |